A role for tissue transglutaminase in α-gliadin peptide cytotoxicity

Clinical and Experimental Immunology

Volumn 146, Issue 3, 2006, Pages 550-558

  Sakly, W ^a,b   Thomas, V ^a   Quash, G ^a   El Alaoui, S ^a  

^a Covalab ^*  (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Coeliac disease; Gliadin peptides; Transglutaminase

Indexed keywords

GLIADIN; GLUTAMIC ACID; GLUTAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SYNTHETIC PEPTIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL STRAIN; CELL STRAIN CACO 2; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEAMINATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR CELL;

CACO-2 CELLS; CELIAC DISEASE; CELL DIVISION; CELLS, CULTURED; DEAMINATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLIADIN; HUMANS; PEPTIDE FRAGMENTS; TRANSGLUTAMINASES;

EID: 33750893192     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03236.x     Document Type: Article

References (42)

1. Sollid M. Molecular basis of coeliac disease. Ann Rev Immunol 2000; 18:53-81.
2. Walker Smith JA, Guandalini S, Schmitz J, Sherling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65:909-11.
3. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11:1185-94.
4. Vader W, Stepniak D, Kooy Y et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci 2003; 100:12390-5.
5. Folk JE, Finlayson JS. The Nε-(γ-glutamyl) lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 1977; 31:1-133.
6. Birckbichler PJ, Dowben RM, Matacic S, Loewy AG. Isopeptide bonds in membrane proteins from eukaryotic cells. Biochim Biophys Acta 1973; 291:149-55.
7. Molberg O, McAdam S, Lundin KE et al. T cells from coeliac disease lesions recognise gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 2001; 31:1317-23.
8. Quarsten H, Molberg O, Fugger L, McAdam SM, Sollid LM. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol 1999; 29:2506-14.
9. Novak P, Man P, Tuckova L, Tlaskalova-Hogenova H, Bezouska K, Havlicek V. Monitoring of in vitro deamidation of gliadin peptic fragment by mass spectrometry may reflect one of the molecular mechanisms taking place in coeliac disease development. J Mass Spectrom 2002; 37:507-11.
10. Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 2002; 283:996-1003.
11. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AVS. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000; 6:337-42.
12. Arentz-Hansen H, Korner R, Molberg O et al. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000; 191:603-12.
13. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ (a1*0501,b1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178:187-96.
14. Shan L, Molberg O, Parrot I et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297:2275-9.
15. Martucci S, Fraser JS, Biagi F, Corazza GR, Ciclitira PJ, Ellis HJ. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system. Eur J Gastroenterol Hepatol 2003; 15:1293-8.
16. Fraser JS, Engel W, Ellis HJ et al. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 2003; 52 (12):1698-702.
17. Hudson DA, Cornell HJ, Purdham DR, Rolles CJ. Non-specific cytotoxicity of wheat gliadin components towards cultured human cells. Lancet 1976; 14 (1):339-41.
18. Dolfini E, Elli L, Dasdia T et al. In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line. Toxicol Vitro 2002; 16:331-7.
19. Giovannini C, Maiuri L, De Vincenzi M. Cytotoxic effect of prolamin-derived peptides on in vitro cultures of cell line Caco-2: implications for coeliac disease. Toxicol In Vitro 1994; 9:251-5.
20. Auricchio S, De Ritis G, De Vincenzi M et al. Agglutinating activity of gliadin-derived peptides from bread wheat: implications for coeliac disease pathogenesis. Biochem Biophys Res Commun 1984; 121:428-33.
21. De Vincenzi M, Stammati A, Luchetti R, Silano M, Gasbarrini G, Silano V. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562 (S) cells. Toxicology 1998; 127:97-106.
22. Giovannini C, Sanchez M, Straface E, Scazzocchio B, Silano M, De Vincenzi M. Induction of apoptosis in caco-2 cells by wheat gliadin peptides. Toxicology 2000; 145 (1):63-71.
23. Giovannini C, Matarrese P, Scazzocchio B et al. Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway. FEBS Lett 2003; 540 (1-3):117-24.
24. Rivabene R, Mancini E, De Vincenzi M. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease. Biochim Biophys Acta 1999; 1453:152-60.
25. Clemente MG, De Virgiliis S, Kang JS et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003; 52:218-23.
26. Giovannini C, Lucchetti R, De Vincenzi M. The activities of peptides '31-43', '44-55' and '56-68' of A-gliadin on in vitro cultures of Caco-2 cells. ATLA 1997; 25:437-43.
27. Giovannini C, Mancini E, De Vincenzi M. Inhibition of the cellular metabolism of Caco-2 cells by prolamin peptides from cereals toxic for coeliacs. Toxicol In Vitro 1996; 10:533-8.
28. Nikulina M, Habich C, Floh B, Scott F, Kolb H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J Immunol 2004; 173:1925-33.
29. Vader W, Kooy Y, van Veelen P et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002; 122:1729-37.
30. Sugimura Y, Hosono M, Wada F, Yoshimura T, Maki M, Hitomi K. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. J Biol Chem 2006; 281:17699-706.
31. Molberg O, McAdam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut derived T cells in celiac disease. Nat Med 1998; 4:713-7.
32. Elli L, Dolfini E, Bardella MT. Gliadin cytotoxicity and in vitro cell cultures. Toxicol Lett 2003; 146:1-8.
33. El Alaoui S, Legastelois S, Roch AM, Chantepie J, Quash G. Transglutaminase activity and N epsilon (gamma glutamyl) lysine isopeptide levels during cell growth: an enzymic and immunological study. Int J Cancer 1991; 48 (2):221-6.
34. Thomas V, El Alaoui S, Massignon D, Clement S, Simonet F, Quash G. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases. Biotechnol Appl Biochem 2006; 43:171-9.
35. Maiuri L, Ciacci C, Ricciardelli I et al. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterol 2005; 129:1400-13.
36. Fleckenstein B, Molberg O, Qiao SW et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation reactions. J Biol Chem 2002; 277:34109-16.
37. Jones RA, Nicholas B, Mian S, Davies PJ, Griffin M. Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 1997; 110 (19):2461-72.
38. Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000; 41:1-27.
39. Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004; 279:17607-16.
40. Van de Wal Y, Kooy YMC, van Veelen PA et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 1998; 95:10050-4.
41. Kim C-H, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 2004; 101:4175-9.
42. Cooper JK, Schilling G, Peters MF et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 1998; 7:783-90.